Ironwood Pharmaceuticals Inc
LINZESS
functional constipation (FC) in patients 2 to 5 years of age
Resolved
44days ago
FDA decision · May 24, 2026
What's at stake
The FDA's approval decision on LINZESS for functional constipation (FC) in patients 2 to 5 years of age is due May 24, 2026. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 16h ago
“The FDA assigned a Prescription Drug User Fee Act (PDUFA) date of May 24th.”